Journals / Akademik Acil Tıp Dergisi / 2012 / Cilt: 11 - Sayı: 2

Uludağ üniversitesi tıp fakültesi araştırma hastanesi acil servisinde kan ve kan ürünleri transfüzyonu yapılan hastaların epidemiyolojik incelemesi

Uludag university medical faculty research hospital emergency service an epidemiological ınvestigation into blood and blood product transfusion

Pages
61–67
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In light of our findings, it can be seen that many transfusions are performed in the emergency department, transfusion protocols are not normally followed and most transfusions are performed to support the out- patient clinic. (JAEM 2012; 11: 61-7)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study was designed prospectively to investigate the demo- graphic data of patients (n=434) who received blood and blood products at the Uludag University Medical Faculty Research Hospital Emergency Service between June 2009 and December 2009.
📊
Key Findings & Data:Materials and Methods: 83.0% patients had normal vital parameters, 3.4% had hypotension, 2.1% had tachycardia, 1.1% had fever, 9.7% had hypo- tension and tachycardia and 0.7% had hypotension, tachycardia and fever.
💡
Conclusion & Impact:Conclusion: In light of our findings, it can be seen that many transfusions are performed in the emergency department, transfusion protocols are not normally followed and most transfusions are performed to support the out- patient clinic. (JAEM 2012; 11: 61-7)
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: This study was designed prospectively to investigate the demo- graphic data of patients (n=434) who received blood and blood products at the Uludag University Medical Faculty Research Hospital Emergency Service between June 2009 and December 2009. The indications for the blood prod- ucts used, the amount and the type of products used and the documentation of reactions were investigated and compared with data in the literature. Materials and Methods: 83.0% patients had normal vital parameters, 3.4% had hypotension, 2.1% had tachycardia, 1.1% had fever, 9.7% had hypo- tension and tachycardia and 0.7% had hypotension, tachycardia and fever. In terms of hemoglobin levels, 40.6% of patients had a level below 7 g/dL, 13.1% were between 7-8 g/dL, 26.7% were between 8-10 g/dL and 19.6% were above 10 g/dL. The patients who were transfused with an erythrocyte suspension were mostly the group who had a hemoglobin level below 7 g/ dL. Platelets were transfused mostly for thrombocytopenia in patients with a platelet count between 10-20 x 103/mm3. Results: Of all transfused patients, 3.9% had an acute complication related to transfusion. 1.2% of these were acute febrile non-hemolytic reactions (FNHR), 1.1% were heart failure, 0.9% were allergic reactions and 0.7% were both FNHR and allergic reactions. 76.5% of all transfused patients were discharged from the emergency department, 19.4% were hospitalized, 2.5% were sent to other hospitals and 1.6% died in the emergency department. Conclusion: In light of our findings, it can be seen that many transfusions are performed in the emergency department, transfusion protocols are not normally followed and most transfusions are performed to support the out- patient clinic. (JAEM 2012; 11: 61-7)

Özet

Amaç: Bu çalışma, 01.06. 2009-31.12. 2009 tarihleri arasında Uludağ Üniversi- tesi Sağlık Uygulama ve Araştırma Hastanesi Acil Servisinde kan ve kan ürünü transfüzyonu yapılan hastaların (n=434) demografik özelliklerini, transfüzyon endikasyonlarını, kullanılan kan ürünü miktar ve cinsi ile gelişen reaksiyonları- nı dökümante etmek amacıyla prospektif olarak yapılmıştır. Gereç ve Yöntemler: Hastalar vital parametreleri değerlendirildiğinde, %83’ünde patoloji saptanmamış, %3.4’ünde hipotansiyon, %2.1’inde taşi- kardi %1.1’inde ateş, %9.7’sinde hipotansiyon + taşikardi ve %0.7’sinde ise hipotansiyon+ taşikardi + ateş olduğu görülmüştür. Transfüzyon yapılan has- talar hemoglobin miktarı açısından incelendiğinde %40.6’sının 7g/dL altında, %13.1’inin 7-8 g/dL arasında, %26.7’sinin 8-10 g/dL arasında ve %19.6’sının 10 g/dL üstünde olduğu belirlenmiştir. Eritrosit süspansiyonu en çok hemog- lobin değerleri 7 g/dL altında olan hastalara, trombosit süspansiyonu ise en çok trombosit sayısı 10-20x103/mm3 arasında olan hastalara verilmiştir. Taze donmuş plazma transfüzyonu yapılan hastaların %51’inde oral antikoagülan kullanımına bağlı kanama olduğu tespit edilmiştir. Bulgular: Transfüzyon yapılan hastaların %3.9’unda transfüzyonla ilişkili akut komplikasyonlar gelişmiştir. Bu komplikasyonlar incelendiğinde %1.2’sinin akut febril nonhemolitik reaksiyon (FNHR), %1.1’inin dolaşım yüklenmesi, %0.9’unun alerjik reksiyon, %0.7’sinin ise hem FNHR hem de alerjik reaksiyon olduğu gözlenmiştir. Transfüzyon yapılan hastaların %76.5’i acil servisten ta- burcu edilmiş, %19.4’ü hastaneye yatırılmış, %2.5’i başka bir sağlık kuruluşuna sevk edilmiş ve %1.6’sı da acil serviste ölmüştür. Sonuç: Çalışmamız süresince elde ettiğimiz tüm bu tespitler ışığında, acil serviste çok sayıda transfüzyon yapıldığını, endikasyon belirlemede belirli bir protokole bağlı kalınmadığını ve daha çok poliklinik takibinde olan hastalara ve destek niteliğinde transfüzyon yapıldığını söyleyebiliriz. (JAEM 2012; 11: 61-7)

🔖

Cite This Article

ESEN, M., AYDIN, Ş. A., ÖNER, N., ÖZDEMİR, F., KÖKSAL, Ö. (2022). Uludağ üniversitesi tıp fakültesi araştırma hastanesi acil servisinde kan ve kan ürünleri transfüzyonu yapılan hastaların epidemiyolojik incelemesi. Akademik Acil Tıp Dergisi, Cilt: 11 - Sayı: 2, 61–67. https://ajindex.com/articles/431644

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Vengelen-Tyler V. Noninfectious Complications of Blood Transfusion. In Technical Manual. 12th ed. Bethesda, MD: American Association of Blood Banks. 1996; 558-9
  2. American Association of Blood Banks, Technical Manual. Non-infectious Complications of blood transfusion, 1999; 577-600
  3. Serious hazards of transfusion annual report 1999-2000 (internet). Manchester (UK): SHOT Office; accessed 2003 Dec 12
  4. Hillman RS, Kenneth AA. Blood Component Therapy. In: Hematology in Clinical practice 3rd ed. 2002; 407-16
  5. Heddle NM. Patophysiology Of Febrile Non-Hemolytic Transfusion Reaktions. Curr Opin Hematol. 1999; 6: 420-6. [CrossRef] 6. Heddle NM, Kelton JG. Febrile nonhemolytic transfusion reactions, in Popovsky M (ed): Transfusion Reactions (ed 2). Bethesda, MD, AABB Press, 2001, pp 45-82
  6. Serious Hazards Of Transfusion Annual Report 1998-1999 (İnternet). Manchester (UK): SHOT Office; Accessed 2003 Dec 12
  7. Hillman RS, Ault KA. Blood Component Therapy. In: Hillman RS, Ault KA, Rinder HM (Eds.). Hematology in Clinical Practice. 4rd ed. New York: Mc Graw Hill, 2005; 431-41
  8. Hardy JF. Current status of transfusion triggers for red blood cell concen- trates. Transfusion and Apheresis Science. 2004; 31: 55-66. [CrossRef] 10. Hajjar LA, Auler Junior JOC, Santos L, Galas F. Blood transfusion in criti- cally ill patients: state of the art.Clinics; 2007; 62: 507-24. [CrossRef] 11. Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood trans- fusion. Transfusion 2002; 42: 812-8. [CrossRef] JAEM 2012; 11: 61-7 12. Kristen C. Sihler,Lena M. Napolitano. Anemia of ınflammation in critically ill patients. Journal of intensive care medicine. 2008; 23: 295-302. [CrossRef] 13. Howell PJ, Bamber PA. Severe acute anaemia in a Jehovah’s Witness. Survival without blood transfusion. Anaesthesia. 1987; 42: 44-8. [CrossRef] 14. Marshall JC. Transfusion trigger:when to transfuse? Critical Care. 2004; 8: 31-3. [CrossRef] 15. Chohan SS, McArdle F, McClelland DB, Mackenzie SJ, Walsh TS. Redcell transfusion practice following the transfusion requrements in critical care (TRICC) study:prospective observational cohort study in a large UK inten- sive care unit. Vox Sanguins. 2003; 84: 211-8. [CrossRef] 16. Corwin HL, Surgenor SD, Gettinger A. Transfusion practice in the critically ill. Crit Care Med. 2003; 31: 668-71. [CrossRef] 17. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et